A drug used to treat asthma has been shown to help reduce the formation of amyloid beta, a peptide that is implicated in the development of Alzheimer’s disease, and the subsequent build up of amyloid plaques in the brain by more than 50 percent.
A drug used to treat asthma has been shown to help reduce the formation of amyloid beta, a peptide that is implicated in the development of Alzheimer’s disease, and the subsequent build up of amyloid plaques in the brain by more than 50 percent.